The action by NICE highlights discussion on both sides of the Atlantic about the cost of PCSK9 inhibitors, which lower LDL cholesterol.
Mary K. Caffrey
Advertisement
Articles by Mary K. Caffrey
GAO made recommendations for safeguards to prevent enrollees from having Medicaid and exchange coverage at the same time.
Advertisement
Latest Updated Articles
Steps Needed to Avoid Gaps, Double Coverage as Medicaid Enrollees Make ACA TransitionsPublished: October 30th 2015 | Updated:
Repatha Gets Early Thumbs Down by Britain's NICEPublished: November 19th 2015 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Operationalizing Epcoritamab-GemOx in Practice: A Focus on EPCORE NHL-2
2
Current and Emerging BCMAxCD3 Bispecifics
3
Amivantamab for EGFR-Mutated Metastatic Non–Small Cell Lung Cancer
4
Same Pathway, Different Profiles: Clinical Considerations for Alpelisib, Capivasertib, and Inavolisib
5
